The anti-metastatic micro-environment of the bone: Importance of osteocyte Cx43 hemichannels

被引:6
作者
Bultynck, Geert [1 ,2 ]
机构
[1] Katholieke Univ Leuven, Lab Mol & Cellular Signaling, Dept Cellular & Mol Med, Campus Gasthuisberg O-N-I Bus 802,Herestr 49, BE-3000 Leuven, Belgium
[2] LKI, Campus Gasthuisberg 0-N-I Bus 802,Herestr 49, BE-3000 Leuven, Belgium
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2016年 / 1866卷 / 01期
关键词
Connexin; Hemichannels; Breast cancer; Metastasis; Bone; Osteocytes; BREAST-CANCER; GAP-JUNCTION; PLASMA-MEMBRANE; GLIOMA INVASION; CONNEXIN-43; BISPHOSPHONATES; CHANNELS; PEPTIDE; METASTASIS; PATHWAY;
D O I
10.1016/j.bbcan.2016.07.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone metastases of tumor cells are a common and life-threatening feature of a variety of late-stage cancers, including breast cancers. However, until now, much less has been known about the intrinsic anti-metastatic properties of the bones and how these could be exploited to prevent or treat bone metastases. Very recently, native Cx43 hemichannels present in osteocytes have been identified as important anti-metastatic signaling complexes by establishing high local extracellular ATP levels. Moreover, bisphosphonate drugs, applied as adjuvant therapies in the treatment of breast cancer patients and bone diseases, are known to display anti-metastatic properties. Now, it became clear that these compounds exert their effects through osteocyte Cx43 hemichannels, thereby triggering their opening and promoting ATP release in the extracellular micro-environment. Hence, endogenous osteocyte Cx43 hemichannels emerge as important and promising therapeutic targets for the prevention of bone metastases and/or clinical treatment of bone-metastasized breast cancers. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 69 条
  • [1] The connexin43 mimetic peptide Gap19 inhibits hemichannels without altering gap junctional communication in astrocytes
    Abudara, Veronica
    Bechberger, John
    Freitas-Andrade, Moises
    De Bock, Marijke
    Wang, Nan
    Bultynck, Geert
    Naus, Christian C.
    Leybaert, Luc
    Giaume, Christian
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [2] Reduction in gap junction intercellular communication promotes glioma migration
    Aftab, Qurratulain
    Sin, Wun-Chey
    Naus, Christian C.
    [J]. ONCOTARGET, 2015, 6 (13) : 11447 - 11464
  • [3] [Anonymous], ONCOGENE
  • [4] Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors
    Beavis, Paul A.
    Divisekera, Upulie
    Paget, Christophe
    Chow, Melvyn T.
    John, Liza B.
    Devaud, Christel
    Dwyer, Karen
    Stagg, John
    Smyth, Mark J.
    Darcy, Phillip K.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (36) : 14711 - 14716
  • [5] Autophagy modulates dynamics of connexins at the plasma membrane in a ubiquitin-dependent manner
    Bejarano, Eloy
    Girao, Henrique
    Yuste, Andrea
    Patel, Bindi
    Marques, Carla
    Spray, David C.
    Pereira, Paulo
    Cuervo, Ana Maria
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2012, 23 (11) : 2156 - 2169
  • [6] Osteocyte-Driven Bone Remodeling
    Bellido, Teresita
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2014, 94 (01) : 25 - 34
  • [7] Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer
    Chen, Qing
    Boire, Adrienne
    Jin, Xin
    Valiente, Manuel
    Er, Ekrem Emrah
    Lopez-Soto, Alejandro
    Jacob, Leni S.
    Patwa, Ruzeen
    Shah, Hardik
    Xu, Ke
    Cross, Justin R.
    Massague, Joan
    [J]. NATURE, 2016, 533 (7604) : 493 - +
  • [8] Chlebowski Rowan T, 2011, Breast Dis, V33, P93, DOI 10.3233/BD-2010-0324
  • [9] Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
    Clayton, Aled
    Al-Taei, Saly
    Webber, Jason
    Mason, Malcolm D.
    Tabi, Zsuzsanna
    [J]. JOURNAL OF IMMUNOLOGY, 2011, 187 (02) : 676 - 683
  • [10] Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
    Coleman, R.
    Powles, T.
    Paterson, A.
    Gnant, M.
    Anderson, S.
    Diel, I.
    Gralow, J.
    von Minckwitz, G.
    Moebus, V.
    Bergh, J.
    Pritchard, K. I.
    Bliss, J.
    Cameron, D.
    Evans, V.
    Pan, H.
    Peto, R.
    Bradley, R.
    Gray, R.
    Bartsch, R.
    Dubsky, P.
    Fesl, C.
    Fohler, H.
    Greil, R.
    Jakesz, R.
    Lang, A.
    Luschin-Ebengreuth, G.
    Marth, C.
    Mlineritsch, B.
    Samonigg, H.
    Singer, C. F.
    Steger, G. G.
    Stoeger, H.
    Olivotto, I.
    Ragaz, J.
    Christiansen, P.
    Ejlertsen, B.
    Ewertz, M.
    Jensen, M-B
    Moller, S.
    Mouridsen, H. T.
    Eiermann, W.
    Hilfrich, J.
    Jonat, W.
    Kaufmann, M.
    Kreienberg, R.
    Schumacher, M.
    Blohmer, J. U.
    Costa, S. D.
    Eidtmann, H.
    Gerber, B.
    [J]. LANCET, 2015, 386 (10001) : 1353 - 1361